期刊文献+

肠出血性大肠杆菌O157∶H7 EspA与IntiminC300融合蛋白的构建表达 被引量:5

Construction and expression of fusion protein EspA-IntiminC300 from Enterohemorrhagic Escherichia coli O157∶H7
下载PDF
导出
摘要 目的构建表达肠血性大肠杆菌(EHEC)O157∶H7Ⅲ型分泌蛋白EspA与紧密粘附素C-端免疫保护性片断(IntiminC300)的融合蛋白(EspA-IntiminC300)。方法采用PCR技术从EHEC O157∶H7基因组中扩增EspA的编码基因espA及IntiminC300的编码基因eaeC300,T-A克隆后依次构建至表达载体pET-28a(+),转化宿主细胞E.coliBL21(DE3),测序鉴定,IPTG诱导表达,SDS-PAGE检测其表达量及表达形式,亲和层析法纯化目的蛋白,免疫印迹分析免疫反应性。结果PCR法自EHEC O157∶H7基因组中分别扩增出了约580bp(espA)和900bp(eaeC300)的目的片段,将二者融合构建了重组质粒pET-28a(+)-espA-eaeC300,测序结果与理论预测值一致性为99.9%(1501/1502)。融合蛋白在工程菌中表达量约40%,PAGE初步测定目的蛋白的相对分子量(Mr)约54×103Da,破菌后电泳证实目的蛋白主要以包涵体形式表达,包涵体洗涤后纯化,获得目的蛋白纯度约90%。免疫印迹显示融合蛋白能分别与兔抗EspA和IntiminC300血清发生免疫反应。结论高效表达了融合蛋白(EspA-IntiminC300),此融合蛋白具有良好的免疫反应性和免疫原性,为研制EHECO157∶H7多亚单疫苗奠定了基础。 To construct and prokaryotically express the fusion protein of EspA and IntinminC300 from EHEC O157 , H7,the coding genes of EspA (espA) and IntinminC300 (eaeC300) was amplified by PCR from EHEC O157 , H7 chromosome and then cloned into pMD-18T vector. Thereafter target genes cloned into pET-28a(+) vector in turn by recombinant technology, and transferred to host cells E. coll BL21 strain (DE3). Then, the protein was induced and expressed with induction of IPTG. The expression quantities and style of fusion protein were determined by SDS-PAGE, and purified by affinity chromatography. Finally, its immunoreactivity was analyzed by Western blotting. The determination of the sequence encording of the espA-eaeC,300 fusion gene has 99. 90% (1501/1502) of consistency with the sequence from GenBank Sakai strain and contrivable linker. The fusion protein EspA-IntinminC300 was expressed as inclusion body formation and the percentage was approximately 40 %. The molecular weight of the expressed product was 54kD. Western blotting demontrated the was excellent immunoreactivity of the fusion protein. It is evident that the fusion protein EspA-IntinminC300 of EHEC O157 t H7 was successfully constructed and well expressed in prokaryotic expression system, and the fusion protein has excellent immunoreactivity. These results may provide the foundation for the further development on EHEC O157 , H7 multivalent subunit vaccine.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2007年第2期106-109,共4页 Chinese Journal of Zoonoses
基金 军队杰出人才基金资助项目(No.04J009)
  • 相关文献

参考文献10

  • 1詹初航.为了明天的食品更安全——陈君石教授谈我国食品安全的现状问题[J].中国卫生,2004(3):32-34. 被引量:20
  • 2Wong CS,Jelacic S,Habeeb RL,et al.The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections[J].N Engl J Med,2000,342:1930-1936.
  • 3Crepin VF,Shaw R,Abe CM,et al.Polarity of Enteropathogenic Escherichia coli EspA Filament Assembly and Protein Secretion[J].Journal of Bacteriology,2005,187:2881-2889.
  • 4Gruenheid S,Sekirov I,Thomas NA,et al.Identification and characterization of NleA,a non-LEE encoded type Ⅲ translocated virulence factor of enterohaemorrhagic Escherichia coli O157 :H7[J].Mol Microbiol,2004,51:1233-1249.
  • 5Mundy R.Petrovska L,Smollett K,et al.Identification of a novel Citrobacter rodentium type Ⅲ secreted protein,Espl,and the roles of this and other secreted proteins in infection[J].Infect Immun,2004,72:2288-2302.
  • 6Potter AA,Klashinsky S,Li Y,et al.Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type Ⅲ secreted proteins[J].Vaccine,2004,22:362-369.
  • 7Yuling Li,Elizabeth Frey,Andrew MR,et al.Finlay September Human Response to Escherichia coli O157:H7 Infection:Antibodies to Secreted Virulence Factors[J].Infection and Immunity,2000.68:5090-5095.
  • 8王庆旭,毛旭虎,邹全明,曾韦锟,罗萍,程建平,易勇,马颖.肠出血性大肠埃希菌O157:H7 espA基因的克隆与表达[J].中华微生物学和免疫学杂志,2006,26(6):535-538. 被引量:7
  • 9Son W G,Graham T A,Gannon V P J.Immunological characterization of Escherichia coli O157:H7 intimin gammal[J].Clin Diagn Lab Immunol,2002,9:46-53.
  • 10易勇,邹全明,程建平,毛旭虎,曾明,朱永红,童文德.肠出血性大肠杆菌O157∶H7紧密黏附素免疫保护性片段的基因克隆与表达[J].中华微生物学和免疫学杂志,2005,25(2):142-145. 被引量:9

二级参考文献31

  • 1汪华,景怀琦,李红卫,倪大新,赵广法,顾玲,杨晋川,史智扬,刘光中,胡晓抒,徐建国.江苏省淮北地区肠出血性大肠埃希菌O157:H7感染性腹泻并发急性肾衰的研究[J].中华流行病学杂志,2004,25(11):938-940. 被引量:45
  • 2权太淑.首次从出血性结肠炎病人中分离到O157:H7大肠杆菌[J].中华流行病学杂志,1988,9:24-24.
  • 3Slutsker L,Ries AA,Maloney K,et al. A nationwide case-control study of Escherichia coli O157∶H7 infection in the United States. J Infect Dis,1998,177(4): 962-966.
  • 4Bell BP,Griffin PM,Lozano P,et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157 infections. Pediatrics,1997,100(1): E12.
  • 5Cornick NA,Booher SL,Moon HW. Intimin facilitates colonization by Escherichia coli O157∶H7 in adult ruminants. Infect Immun,2002,70(5): 2704-2707.
  • 6Fitzhenry RJ,Pickard DJ,Hartland EL,et al. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157∶H7. Gut,2002,50(2): 180-185.
  • 7Son WG,Graham TA,Gannon VPJ,et al. Immunological characterization of Escherichia coli O157∶H7 intimin gamma1. Clin Diagn Lab Immunol,2002,9(1): 46-53.
  • 8Dean NEA,Gansheroff LJ,Mills M,et al. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157∶H7 infection. Infect Immun,2002,70(5): 2414-2418.
  • 9Jenkins C,Chart H,Smith HR,et al. Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus. J Med Microbiol,2000,49(1): 97-101.
  • 10Gansheroff LJ,Wachtel MR,O′Brien AD. Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin. Infect Immun,1999,67(12): 6409-6417.

共引文献33

同被引文献66

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部